Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Certara Releases New Version of D360™, Its Industry-leading Informatics Platform for Pharma Discovery Scientists
Wednesday, February 01, 2017Certara the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes announced that it has released D version along with D Express its data informatics platform for discove...
Neurotrope Completes Licensing Agreement for Accelerated Synthesis of Alzheimer's Drug Bryostatin-1
Tuesday, January 31, 2017Neurotrope Inc a clinicalstage biopharmaceutical company developing novel therapies for neurodegenerative diseases including Alzheimers disease announced today that it has signed a licensing agreement with Stanford University for an accelerated synth...
Charles River Laboratories Announces Progress Update for Collaboration with Moderna Therapeutics
Tuesday, January 31, 2017Charles River Laboratories International Inc a leading earlystage contract research organization CRO today announced a progress update related to its support of Moderna Therapeutics nonclinical discovery and development efforts Since Charles River h...
Rapid emergence of MENA biologics industry sees first ever Biopharma Conference and new venue at CPhI Istanbul 2017
Tuesday, January 31, 2017CPhI Istanbul organised by UBM EMEA in partnership with Pharmaceutical Manufacturers Association of Turkey IEIS returns to Turkey for its fourth edition with a new colocated event BioPh to join ICSE PMEC and InnoPack Taking place March the fivein...
Sunovion’s Latuda® (lurasidone HCl) Receives FDA Approval to Treat Adolescents with Schizophrenia
Saturday, January 28, 2017Sunovion Pharmaceuticals Inc Sunovion today announced that the US Food and Drug Administration FDA approved the supplemental New Drug Application sNDA for Latuda lurasidone HCI for the treatment of schizophrenia in adolescents aged to years LATUDA...
Aurinia Selects Worldwide Clinical Trials as its CRO for Phase 3 Lupus Nephritis Trial
Saturday, January 28, 2017Aurinia Pharmaceuticals Inc a clinical stage biopharmaceutical company focused on the global immunology market today announced that it has selected Worldwide Clinical Trials Worldwide as its Clinical Research Organization CRO for the AURORA Phase st...
New Pharmaceutical Business Line Director appointed at Matcon Ltd.
Friday, January 27, 2017
Vetter Starts Operations in its Center for Visual Inspection and Logistics
Friday, January 27, 2017Vetter a leading global Contract Development and Manufacturing Organization CDMO for development aseptic filling and final packaging of injectables has announced today that it has begun operations in its expanded Visual Inspection and Logics Center l...
Mikron Automation Expands U.S. Headquarters in Metro Denver
Friday, January 27, 2017Mikron Automation and Denverbased Confluent Development are pleased to announce the expansion of Mikron Automations US headquarters in Arapahoe Countys Dove Valley Business Park The industrial facility will expand to include square feet of needed sp...
Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt Disease
Friday, January 27, 2017Acucela Inc a clinicalstage ophthalmology company and whollyowned subsidiary of Kubota Pharmaceutical Holdings Co Ltd Tokyo committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions...
